Riddhi Siddhi Gluco Biols Ltd-$
Riddhi Siddhi Gluco Biols Ltd-$ (RIDDHI) last reported results for the quarter ended Jun 2026, with sales of ₹89.87 crore and net profit of ₹3.01 crore. The stock last traded at ₹702, a market capitalisation of ₹501 crore, on a P/E of 35.4. Over the past 52 weeks the stock has ranged between ₹405 and ₹862. Figures are as of 6 Oct 2026 and are not real time.
Riddhi Siddhi Gluco Biols Ltd-$ share price and key metrics
- Current price
- ₹702
- Market cap
- ₹501 cr
- Stock P/E
- 35.4
- Book value
- ₹2,117
- ROE
- -0.80%
- ROCE
- 2.74%
- Dividend yield
- 0.43%
- 52w high / low
- 862/405
Metrics as of 6 Oct 2026. Not real time.
Track Riddhi Siddhi Gluco Biols Ltd-$
Cruxal reads every Riddhi Siddhi Gluco Biols Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Riddhi Siddhi Gluco Biols Ltd-$ growth and returns
- 10 Years
- -4%
- 5 Years
- -14%
- 3 Years
- 11%
- TTM
- -38%
- 10 Years
- %
- 5 Years
- 12%
- 3 Years
- %
- TTM
- -64%
- 10 Years
- 7%
- 5 Years
- 14%
- 3 Years
- 17%
- 1 Year
- 22%
- 10 Years
- 0%
- 5 Years
- 1%
- 3 Years
- 0%
- Last Year
- -1%
Riddhi Siddhi Gluco Biols Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹89.87 cr, down 41.9% from ₹155 cr a year earlier. Net profit was ₹3.01 cr, down 62.6% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 48.9 | 44.33 | 28.02 | 155 | 32.1 | 40.08 | 9.05 | 89.87 |
| Expenses | 42.48 | 45.09 | 31.47 | 155 | 30.54 | 45.6 | 17.1 | 92.53 |
| Operating profit | 6.42 | -0.76 | -3.45 | -0.25 | 1.56 | -5.52 | -8.05 | -2.66 |
| OPM % | 13.13% | -1.71% | -12.31% | -0.16% | 4.86% | -13.77% | -88.95% | -2.96% |
| Other income | 19.44 | -52.84 | 28.12 | 19.61 | 20.54 | 12.61 | -16.79 | 16.17 |
| Interest | 2.93 | 2.51 | 2.56 | 3.74 | 5.13 | 4.19 | 4.49 | 6.22 |
| Depreciation | 2.04 | 2.16 | 2.14 | 2.05 | 2.06 | 2.08 | 2.04 | 2.3 |
| Profit before tax | 20.89 | -58.27 | 19.97 | 13.57 | 14.91 | 0.82 | -31.37 | 4.99 |
| Tax % | 36.14% | -7.28% | 76.87% | 40.68% | 7.71% | 256.10% | 4.37% | 39.88% |
| Net profit | 13.34 | -54.02 | 4.63 | 8.04 | 13.76 | -1.28 | -32.74 | 3.01 |
| EPS (₹) | 18.93 | -50.56 | 5.09 | 11.05 | 18.99 | -2.23 | -45.64 | 4.29 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Riddhi Siddhi Gluco Biols Ltd-$ annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 508 | 804 | 682 | 576 | 498 | 223 | 173 | 268 | 136 | 236 | 171 |
| Operating profit | -47 | -10 | 85 | 48 | -14 | 24 | 1 | 4 | 3 | -12 | -15 |
| OPM % | -9% | -1.3% | 13% | 8% | -2.7% | 11% | 0.4% | 1.5% | 1.9% | -5% | -9% |
| Net profit | -45 | 9 | 67 | 24 | -62 | 2 | -85 | 44 | -12 | -12 | -17 |
| EPS (₹) | -59.96 | 26.57 | 68.28 | 46.12 | -65.61 | 3.11 | -119.09 | 61.53 | -17.07 | -17.15 | -24.59 |
TTM is the trailing twelve months to the most recent quarter.
Riddhi Siddhi Gluco Biols Ltd-$ balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 1,316 | 1,382 | 1,429 | 1,417 | 1,446 | 1,497 | 1,425 | 1,530 | 1,542 | 1,502 |
| Borrowings | 682 | 474 | 353 | 271 | 229 | 155 | 81 | 73 | 101 | 283 |
| Other liabilities | 367 | 279 | 290 | 295 | 259 | 178 | 179 | 164 | 135 | 99 |
| Total liabilities | 2,373 | 2,143 | 2,078 | 1,991 | 1,941 | 1,838 | 1,692 | 1,774 | 1,784 | 1,891 |
| Fixed assets | 769 | 744 | 723 | 748 | 770 | 738 | 392 | 383 | 434 | 426 |
| CWIP | 2 | 16 | 57 | 66 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 969 | 470 | 352 | 158 | 175 | 198 | 209 | 339 | 307 | 606 |
| Other assets | 633 | 912 | 946 | 1,020 | 995 | 902 | 1,091 | 1,052 | 1,044 | 859 |
| Total assets | 2,373 | 2,143 | 2,078 | 1,991 | 1,941 | 1,838 | 1,692 | 1,774 | 1,784 | 1,891 |
As reported by the company. Total assets equal total liabilities by construction.
Riddhi Siddhi Gluco Biols Ltd-$ cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -284 | -34 | -1 | 116 | 130 | 161 | 1 | 9 | -28 | -9 |
| Cash from investing | 95 | 294 | 170 | 46 | -52 | -70 | 8 | 21 | 21 | -22 |
| Cash from financing | 192 | -263 | -169 | -131 | -108 | -94 | 2 | -41 | 8 | 140 |
| Net cash flow | 3 | -3 | 0 | 31 | -29 | -2 | 11 | -11 | -0 | 108 |
| Free cash flow | -305 | -58 | -51 | 50 | 137 | 160 | 1 | 2 | -73 | 11 |
| CFO / operating profit | 600% | 174% | 9% | 294% | -979% | 746% | 2,300% | 621% | -705% | -46% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Riddhi Siddhi Gluco Biols Ltd-$ operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 1% | 2% | 6% | 3% | 0% | 4% | 3% | 5% | 5% | 3% |
| Debtor days | 32 | 23 | 26 | 156 | 75 | 83 | 91 | 31 | 33 | 13 |
| Inventory days | 424 | 215 | 425 | 204 | 216 | 120 | 13 | 8 | 173 | 79 |
| Days payable | 131 | 44 | 75 | 75 | 80 | 115 | 26 | 12 | 29 | 26 |
| Cash conversion cycle | 325 | 194 | 376 | 285 | 211 | 87 | 77 | 26 | 177 | 66 |
| Working capital days | -34 | 216 | 292 | 379 | 222 | 626 | 1,110 | 636 | 1,153 | 630 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Riddhi Siddhi Gluco Biols Ltd-$ shareholding pattern
Promoters held 75.00% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.67% and DIIs 0.01%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.54% | 74.54% | 74.54% | 74.54% | 74.54% | 74.54% | 86.55% | 75.00% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.67% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 25.45% | 25.45% | 25.45% | 25.45% | 25.45% | 25.45% | 13.43% | 22.31% |
| No. of shareholders | 4,095 | 4,328 | 4,354 | 4,266 | 4,216 | 4,232 | 4,171 | 3,996 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Riddhi Siddhi Gluco Biols Ltd-$ corporate filings
- Closure of Trading WindowInsider Trading / SASTlow impact
Cruxal's analysis: Please find attached intimation for closure of Trading Window.
Read the full analysis - Riddhi Siddhi Gluco Biols Ltd. shifts registered office and revises CIN, no financial impact reportedCompany Updatelow impact
Cruxal's analysis: The company announced a change in its registered office address and a revision in its…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited Announces Voting Results of 35th AGM Including Approval of Material Related Party TransactionAGM/EGMlow impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has successfully concluded its 35th Annual General…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited concludes 35th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has successfully concluded its 35th Annual General…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited receives regulatory approval to shift registered office to HaryanaCompany Updatelow impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has received formal approval from the Hon’ble Regional…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited to Seek Shareholder Approval for INR 200 Crore Related Party Borrowing and Board Appointments at 35th AGMAGM/EGMmedium impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has issued a notice for its 35th Annual General Meeting…
Read the full analysis - Riddhi Siddhi Gluco Biols Ltd submits 35th Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: The company has filed its 35th Annual Report for the financial year 2025-26 in compliance…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited Announces Board Appointments, Auditor Re-appointment, and 35th AGM ScheduleOtherslow impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has announced the appointment of Mr. Taral Shah as an…
Read the full analysis - Riddhi Siddhi Gluco Biols Reports Q1 FY27 Results, Achieves MPS Compliance, and Expands via Starch Division AcquisitionBoard Meetinghigh impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited reported standalone Q1 FY27 revenue of 80.15 crore and…
Read the full analysis - Riddhi Siddhi Gluco Biols Limited schedules Board Meeting for June 2026 quarterly resultsBoard Meetinglow impact
Cruxal's analysis: Riddhi Siddhi Gluco Biols Limited has issued a formal intimation to the BSE regarding a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.